GUi's patient capital fuels tech innovation and enterprise growth

Grand Union of Innovation (GUi) is reshaping venture investment with a 5 billion yuan ($691.16 million) patient capital fund, supporting tech startups from early-stage breakthroughs to large-scale commercialization.

The initiative aligns with the nation's 2025 Government Work Report, which calls for the expansion of patient capital.

Unlike traditional short-term investment models, GUi adopts a "government-led, market-driven, ecosystem-coordinated" strategy and works alongside sub-fund partners to apply an industry-driven investment approach, reinforcing the value of long-termism, with its guiding fund focuses on making sustained investment in technological startups in their early period.

A prime example is Anhui Dendrite Precision Optics Company, a firm developing high-resolution surgical microscopes. Despite being labeled "high-risky" by many agencies, it received backing from Hefei High-tech Venture Investment Management Partnership Company, one of GUi's sub-fund partners since 2020. By 2024, its headquarters relocated to GUi's park, supported by over 1 billion yuan in strategic investment from provincial and municipal government funds.

The company has later developed the world's first handheld device capable of real-time cell nucleus observation, elevating itself as a market leader in this specialized medical field.

Zhong'an Chuanggu in the core area of GUi, where Dendrite Precision Optics is located. [Photo/GUi]

GUi also fosters a collaborative funding network to synergize government-backed and private capitals. Plum Ventures, a key partner of GUi, lifted the Hefei Feynman Technology Company from mires of marketalization by integrating it into Hefei's industrial ecosystem. Similarly, Qinglan Vision, a Harbin Institute of Technology spin-off specializing in infrared imaging, secured investment through GUi's ecosystem, accelerating its transition from prototype to production.

Beyond investment, GUiTEK Service Platform is partnering with the Shanghai, Shenzhen, Beijing, and Hong Kong stock exchanges, jointly committed to the innovation cultivation of enterprises.

Entrepreneurs from GUi attend the Hong Kong Stock Exchange services event on March 5. [Photo/GUi]

GUi's patient capital is a comprehensive system covering fundraising, investment, management, and independence. GUi’s guiding fund expanded to 5 billion yuan, investing in over 100 projects. It combines a "fund + tech-finance + capital market services" model, building an incubation service system, and a collaborative ecosystem.

GUi supports tech companies' growth on a deeper level by offering specialized financial products to meet the gap of traditional bank loans, with credit grants exceeding 700 million yuan in totality for now. It continually upgrades the scale of patient capital to cover the full lifecycle of the companies.